Hematopoietic stem cells are pluripotent and not just "hematopoietic"

Blood Cells, Molecules, and Diseases

Volumn 51, Issue 1, 2013, Pages 3-8

  Ogawa, Makio ^a   LaRue, Amanda C ^a,b,c   Mehrotra, Meenal ^a,c  

^a Center for Disease Prevention and Health Interventions for Diverse Populations   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Hematopoietic stem cell; Pluripotent stem cell; Stem cell plasticity; Tissue regeneration

Indexed keywords

ARTICLE; CELL DIFFERENTIATION; CELL TYPE; HEMATOPOIETIC STEM CELL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; NONHUMAN; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; STEM CELL PLASTICITY;

ANIMALS; CELL DIFFERENTIATION; CELL LINEAGE; GENETIC DISEASES, INBORN; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELLS; HUMANS; PLURIPOTENT STEM CELLS;

EID: 84877126235     PISSN: 10799796     EISSN: 10960961     Source Type: Journal    
DOI: 10.1016/j.bcmd.2013.01.008     Document Type: Article

References (84)

1. Wagers A.J., et al. Little evidence for developmental plasticity of adult hematopoietic stem cells. Science 2002, 297:2256-2259.
2. Theise N.D., Krause D.S., Sharkis S. Comment on "Little evidence for developmental plasticity of adult hematopoietic stem cells". Science 2003, 299:1317. (author reply 1317).
3. Wagers A.J., Weissman I.L. Plasticity of adult stem cells. Cell 2004, 116:639-648.
4. Smith L.G., Weissman I.L., Heimfeld S. Clonal analysis of hematopoietic stem-cell differentiation in vivo. Proc. Natl. Acad. Sci. U. S. A. 1991, 88:2788-2792.
5. Osawa M., et al. Long-term lymphohematopoietic reconstitution by a single CD34-low/negative hematopoietic stem cell. Science 1996, 273:242-245.
6. Matsuzaki Y., et al. Unexpectedly efficient homing capacity of purified murine hematopoietic stem cells. Immunity 2004, 20:87-93.
7. Masuya M., et al. Hematopoietic origin of glomerular mesangial cells. Blood 2003, 101:2215-2218.
8. Abe T., Masuya M., Ogawa M. An efficient method for single hematopoietic stem cell engraftment in mice based on cell-cycle dormancy of hematopoietic stem cells. Exp. Hematol. 2010, 38:603-608.
9. Okabe M., et al. 'Green mice' as a source of ubiquitous green cells. FEBS Lett. 1997, 407:313-319.
10. Tsuji K., Zsebo K.M., Ogawa M. Enhancement of murine blast cell colony formation in culture by recombinant rat stem cell factor, ligand for c-kit. Blood 1991, 78:1223-1229.
11. Ogawa M., LaRue A.C., Drake C.J. Hematopoietic origin of fibroblasts/myofibroblasts: its pathophysiologic implications. Blood 2006, 108:2893-2896.
12. Hess D.C., et al. Hematopoietic origin of microglial and perivascular cells in brain. Exp. Neurol. 2004, 186:134-144.
13. LaRue A.C., et al. Hematopoietic origins of fibroblasts: I. In vivo studies of fibroblasts associated with solid tumors. Exp. Hematol. 2006, 34:208-218.
14. Lang H., et al. Contribution of bone marrow hematopoietic stem cells to adult mouse inner ear: mesenchymal cells and fibrocytes. J. Comp. Neurol. 2006, 496:187-201.
15. Visconti R.P., et al. An in vivo analysis of hematopoietic stem cell potential: hematopoietic origin of cardiac valve interstitial cells. Circ. Res. 2006, 98:690-696.
16. Fujita J., et al. Administration of granulocyte colony-stimulating factor after myocardial infarction enhances the recruitment of hematopoietic stem cell-derived myofibroblasts and contributes to cardiac repair. Stem Cells 2007, 25:2750-2759.
17. Miyata E., et al. Hematopoietic origin of hepatic stellate cells in the adult liver. Blood 2008, 111:2427-2435.
18. Ebihara Y., et al. Hematopoietic origins of fibroblasts: II. In vitro studies of fibroblasts, CFU-F, and fibrocytes. Exp. Hematol. 2006, 34:219-229.
19. Friedenstein A.J., Chailakhyan R.K., Gerasimov U.V. Bone marrow osteogenic stem cells: in vitro cultivation and transplantation in diffusion chambers. Cell Tissue Kinet. 1987, 20:263-272.
20. Friedenstein A.J., Gorskaja J.F., Kulagina N.N. Fibroblast precursors in normal and irradiated mouse hematopoietic organs. Exp. Hematol. 1976, 4:267-274.
21. Bucala R. Fibrocytes: discovery of a circulating connective tissue cell progenitor. Fibrocytes: New Insights into Tissue Repair and Systemic Fibroses 2007, 1-18. World Scientific Publishing Co. Pte. Ltd., Hackensack. R. Bucala (Ed.).
22. Sera Y., et al. Hematopoietic stem cell origin of adipocytes. Exp. Hematol. 2009, 37:1108-1120. (1120 e1-4).
23. Crossno J.T., et al. Rosiglitazone promotes development of a novel adipocyte population from bone marrow-derived circulating progenitor cells. J. Clin. Invest. 2006, 116:3220-3228.
24. Scadden D.T. The weight of cell identity. J. Clin. Invest. 2007, 117:3653-3655.
25. Koh Y.J., et al. Bone marrow-derived circulating progenitor cells fail to transdifferentiate into adipocytes in adult adipose tissues in mice. J. Clin. Invest. 2007, 117:3684-3695.
26. Hausman G.J., Hausman D.B. Search for the preadipocyte progenitor cell. J. Clin. Invest. 2006, 116:3103-3106.
27. Mehrotra M., et al. Hematopoietic stem cells give rise to osteo-chondrogenic cells. Blood Cells Mol. Dis. 2013, 50:41-49.
28. Frost H.M. Metabolism of bone. N. Engl. J. Med. 1973, 289:864-865.
29. Olmsted-Davis E.A., et al. Primitive adult hematopoietic stem cells can function as osteoblast precursors. Proc. Natl. Acad. Sci. U. S. A. 2003, 100:15877-15882.
30. Horwitz E.M., et al. Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta. Nat. Med. 1999, 5:309-313.
31. Horwitz E.M., et al. Clinical responses to bone marrow transplantation in children with severe osteogenesis imperfecta. Blood 2001, 97:1227-1231.
32. Mehrotra M., et al. Amelioration of a mouse model of osteogenesis imperfecta with hematopoietic stem cell transplantation: microcomputed tomography studies. Exp. Hematol. 2010, 38:593-602.
33. Baron R., et al. Increased bone turnover with decreased bone formation by osteoblasts in children with osteogenesis imperfecta tarda. Pediatr. Res. 1983, 17:204-207.
34. Rauch F., et al. Static and dynamic bone histomorphometry in children with osteogenesis imperfecta. Bone 2000, 26:581-589.
35. Petersen B.E., et al. Bone marrow as a potential source of hepatic oval cells. Science 1999, 284:1168-1170.
36. Petersen B.E., Zajac V.F., Michalopoulos G.K. Hepatic oval cell activation in response to injury following chemically induced periportal or pericentral damage in rats. Hepatology 1998, 27:1030-1038.
37. Theise N.D., et al. Derivation of hepatocytes from bone marrow cells in mice after radiation-induced myeloablation. Hepatology 2000, 31:235-240.
38. Lagasse E., et al. Purified hematopoietic stem cells can differentiate into hepatocytes in vivo. Nat. Med. 2000, 6:1229-1234.
39. Vassilopoulos G., Wang P.R., Russell D.W. Transplanted bone marrow regenerates liver by cell fusion. Nature 2003, 422:901-904.
40. Newsome P.N., et al. Human cord blood-derived cells can differentiate into hepatocytes in the mouse liver with no evidence of cellular fusion. Gastroenterology 2003, 124:1891-1900.
41. Ferrari G., et al. Muscle regeneration by bone marrow-derived myogenic progenitors. Science 1998, 279:1528-1530.
42. Bittner R.E., et al. Recruitment of bone-marrow-derived cells by skeletal and cardiac muscle in adult dystrophic mdx mice. Anat. Embryol. (Berl) 1999, 199:391-396.
43. Gussoni E., et al. Dystrophin expression in the mdx mouse restored by stem cell transplantation. Nature 1999, 401:390-394.
44. LaBarge M.A., Blau H.M. Biological progression from adult bone marrow to mononucleate muscle stem cell to multinucleate muscle fiber in response to injury. Cell 2002, 111:589-601.
45. Camargo F.D., et al. Single hematopoietic stem cells generate skeletal muscle through myeloid intermediates. Nat. Med. 2003, 9:1520-1527.
46. Krause D.S., et al. Multi-organ, multi-lineage engraftment by a single bone marrow-derived stem cell. Cell 2001, 105:369-377.
47. Kassmer S.H., Krause D.S. Detection of bone marrow-derived lung epithelial cells. Exp. Hematol. 2010, 38:564-573.
48. Orlic D., et al. Bone marrow cells regenerate infarcted myocardium. Nature 2001, 410:701-705.
49. Orlic D., et al. Mobilized bone marrow cells repair the infarcted heart, improving function and survival. Proc. Natl. Acad. Sci. U. S. A. 2001, 98:10344-10349.
50. Murry C.E., et al. Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts. Nature 2004, 428:664-668.
51. Balsam L.B., et al. Haematopoietic stem cells adopt mature haematopoietic fates in ischaemic myocardium. Nature 2004, 428:668-673.
52. Nygren J.M., et al. Bone marrow-derived hematopoietic cells generate cardiomyocytes at a low frequency through cell fusion, but not transdifferentiation. Nat. Med. 2004, 10:494-501.
53. Bergmann O., et al. Evidence for cardiomyocyte renewal in humans. Science 2009, 324:98-102.
54. Friedenstein A.J., Chailakhjan R.K., Lalykina K.S. The development of fibroblast colonies in monolayer cultures of guinea-pig bone marrow and spleen cells. Cell Tissue Kinet. 1970, 3:393-403.
55. Javazon E.H., Beggs K.J., Flake A.W. Mesenchymal stem cells: paradoxes of passaging. Exp. Hematol. 2004, 32:414-425.
56. Bianco P., Robey P.G., Simmons P.J. Mesenchymal stem cells: revisiting history, concepts, and assays. Cell Stem Cell 2008, 2:313-319.
57. Horwitz E.M., et al. Clarification of the nomenclature for MSC: the International Society for Cellular Therapy position statement. Cytotherapy 2005, 7:393-395.
58. Otsuru S., et al. Transplanted bone marrow mononuclear cells and MSCs impart clinical benefit to children with osteogenesis imperfecta through different mechanisms. Blood 2012, 120:1933-1941.
59. Wagner J.E., et al. Bone marrow transplantation for recessive dystrophic epidermolysis bullosa. N. Engl. J. Med. 2010, 363:629-639.
60. Tolar J., et al. Amelioration of epidermolysis bullosa by transfer of wild-type bone marrow cells. Blood 2009, 113:1167-1174.
61. Hudson B.G., et al. Alport's syndrome, Goodpasture's syndrome, and type IV collagen. N. Engl. J. Med. 2003, 348:2543-2556.
62. Rheault M.N., et al. Mouse model of X-linked Alport syndrome. J. Am. Soc. Nephrol. 2004, 15:1466-1474.
63. Cosgrove D., et al. Collagen COL4A3 knockout: a mouse model for autosomal Alport syndrome. Genes Dev. 1996, 10:2981-2992.
64. Sugimoto H., et al. Bone-marrow-derived stem cells repair basement membrane collagen defects and reverse genetic kidney disease. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:7321-7326.
65. Prodromidi E.I., et al. Bone marrow-derived cells contribute to podocyte regeneration and amelioration of renal disease in a mouse model of Alport syndrome. Stem Cells 2006, 24:2448-2455.
66. Klebanov S., et al. Adipose tissue transplantation protects ob/ob mice from obesity, normalizes insulin sensitivity and restores fertility. J. Endocrinol. 2005, 186:203-211.
67. Spalding K.L., et al. Dynamics of fat cell turnover in humans. Nature 2008, 453:783-787.
68. Six I., et al. Beneficial effect of pharmacological mobilization of bone marrow in experimental cerebral ischemia. Eur. J. Pharmacol. 2003, 458:327-328.
69. Shyu W.C., et al. Functional recovery of stroke rats induced by granulocyte colony-stimulating factor-stimulated stem cells. Circulation 2004, 110:1847-1854.
70. Gibson C.L., Bath P.M., Murphy S.P. G-CSF reduces infarct volume and improves functional outcome after transient focal cerebral ischemia in mice. J. Cereb. Blood Flow Metab. 2005, 25:431-439.
71. Schneider A., et al. The hematopoietic factor G-CSF is a neuronal ligand that counteracts programmed cell death and drives neurogenesis. J. Clin. Invest. 2005, 115:2083-2098.
72. Pabst R., Sterzel R.B. Cell renewal of glomerular cell types in normal rats. an autoradiographic analysis. Kidney Int. 1983, 24:626-631.
73. Ito T., et al. Bone marrow is a reservoir of repopulating mesangial cells during glomerular remodeling. J. Am. Soc. Nephrol. JASN 2001, 12:2625-2635.
74. Naruse K., et al. CD34 expression as a novel marker of transformed mesangial cells in biopsied glomerular diseases. J. Pathol. 1999, 189:105-111.
75. Prockop D.J., Olson S.D. Clinical trials with adult stem/progenitor cells for tissue repair: let's not overlook some essential precautions. Blood 2007, 109:3147-3151.
76. Asahara T., et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997, 275:964-967.
77. Asahara T., et al. Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ. Res. 1999, 85:221-228.
78. Takahashi T., et al. Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat. Med. 1999, 5:434-438.
79. Kalka C., et al. Vascular endothelial factor (VEGF): therapeutic angiogenesis and vasculogenesis in the treatment of cardiovascular disease. Med. Klin. (Munich) 1999, 94:193-201.
80. Lyden D., et al. Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth. Nat. Med. 2001, 7:1194-1201.
81. Grant M.B., et al. Adult hematopoietic stem cells provide functional hemangioblast activity during retinal neovascularization. Nat. Med. 2002, 8:607-612.
82. Bailey A.S., et al. Myeloid lineage progenitors give rise to vascular endothelium. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:13156-13161.
83. Ziegelhoeffer T., et al. Bone marrow-derived cells do not incorporate into the adult growing vasculature. Circ. Res. 2004, 94:230-238.
84. Rajantie I., et al. Adult bone marrow-derived cells recruited during angiogenesis comprise precursors for periendothelial vascular mural cells. Blood 2004, 104:2084-2086.